| 000 | 01612 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514185227.0 | ||
| 264 | 0 | _c20040722 | |
| 008 | 200407s 0 0 eng d | ||
| 022 | _a0306-4530 | ||
| 024 | 7 |
_a10.1016/S0306-4530(03)00104-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCleare, A J | |
| 245 | 0 | 0 |
_aLevels of DHEA and DHEAS and responses to CRH stimulation and hydrocortisone treatment in chronic fatigue syndrome. _h[electronic resource] |
| 260 |
_bPsychoneuroendocrinology _cJul 2004 |
||
| 300 |
_a724-32 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBody Mass Index |
| 650 | 0 | 4 | _aCorticotropin-Releasing Hormone |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 |
_aDehydroepiandrosterone _xblood |
| 650 | 0 | 4 |
_aDehydroepiandrosterone Sulfate _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aFatigue Syndrome, Chronic _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrocortisone _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMatched-Pair Analysis |
| 650 | 0 | 4 | _aPituitary-Adrenal Function Tests |
| 650 | 0 | 4 |
_aPituitary-Adrenal System _xdrug effects |
| 650 | 0 | 4 | _aReference Values |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 700 | 1 | _aO'Keane, V | |
| 700 | 1 | _aMiell, J P | |
| 773 | 0 |
_tPsychoneuroendocrinology _gvol. 29 _gno. 6 _gp. 724-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0306-4530(03)00104-5 _zAvailable from publisher's website |
| 999 |
_c14821839 _d14821839 |
||